Results 91 to 100 of about 278,909 (163)

The Use of Cefiderocol in Gram-Negative Bacterial Infections at International Medical Center, Jeddah, Saudi Arabia. [PDF]

Antibiotics (Basel)
Kaki R, Taj A, Bagaaifar S.
europepmc   +1 more source

Mortality Risk of Colistin vs. Non-Colistin Use in Cancer Patients with Multidrug-Resistant Gram-Negative Bacterial Infections: Stratified by Resistance Profile and Concomitant Medications. [PDF]

Medicina (Kaunas)
Lee SH, Choi Y, Choi CY, Choi YJ, Shin S.   +4 more
europepmc   +1 more source

Corrigendum: Understanding the burden of antibiotic resistance: a decade of carbapenem-resistant Gram-negative bacterial infections in Italian intensive care units. [PDF]

Front Microbiol
Scaglione G, Perego M, Colaneri M, Genovese C, Brivio F, Covizzi A, Viaggi B, Bandera A, Gori A, Finazzi S, Palomba E.   +10 more
europepmc   +1 more source

Type 5 secretion system antigens as vaccines against Gram-negative bacterial infections. [PDF]

NPJ Vaccines
Da Costa RM, Rooke JL, Wells TJ, Cunningham AF, Henderson IR.   +4 more
europepmc   +1 more source

Dual-Functional Antibiotic Adjuvant Displays Potency against Complicated Gram-Negative Bacterial Infections and Exhibits Immunomodulatory Properties. [PDF]

ACS Cent Sci
Dhanda G, Singh H, Gupta A, Abdul Mohid S, Biswas K, Mukherjee R, Mukherjee S, Bhunia A, Nair NN, Haldar J.   +9 more
europepmc   +1 more source

Gram-Negative Bacterial Infections in Cardiac Implantable Electronic Devices: Insights from a Retrospective Analysis of Multidrug-Resistant and Non-Multidrug-Resistant Isolates. [PDF]

Pathogens
Schinas G, Koros R, Ntalakouras I, Sideris S, Perperis A, Leventopoulos G, Davlouros P, Akinosoglou K.   +7 more
europepmc   +1 more source

Pharmacokinetics and pharmacodynamics of bacteriophage therapy: a review with a focus on multidrug-resistant Gram-negative bacterial infections. [PDF]

Clin Microbiol Rev
Siopi M, Skliros D, Paranos P, Koumasi N, Flemetakis E, Pournaras S, Meletiadis J.   +6 more
europepmc   +1 more source

Development of novel antimicrobials with engineered endolysin LysECD7-SMAP to combat Gram-negative bacterial infections. [PDF]

J Biomed Sci
Vasina DV, Antonova NP, Gushchin VA, Aleshkin AV, Fursov MV, Fursova AD, Gancheva PG, Grigoriev IV, Grinkevich P, Kondratev AV, Kostarnoy AV, Lendel AM, Makarov VV, Nikiforova MA, Pochtovyi AA, Prudnikova T, Remizov TA, Shevlyagina NV, Siniavin AE, Smirnova NS, Terechov AA, Tkachuk AP, Usachev EV, Vorobev AM, Yakimakha VS, Yudin SM, Zackharova AA, Zhukhovitsky VG, Logunov DY, Gintsburg AL.   +29 more
europepmc   +1 more source

Cost-effectiveness analysis of polymyxin B versus colistin for treating patients with carbapenem-resistant gram-negative bacterial infections. [PDF]

Sci Rep
Wang Y, Yu L, Zhu J, Liang G, Liu J, Zheng Y, Zhao Y, Yu Z.   +7 more
europepmc   +1 more source

Epidemiology and Clinical Outcome of Common Multi-drug Resistant Gram-negative Bacterial Infections in a Network of Hospitals in India (IMPRES): A Multicenter Intensive Care Unit-based Prospective Clinical Study. [PDF]

Indian J Crit Care Med
Das SK, Joshi Z, Govil D, Shah MS, Jakaraddi GN, Sinha S, Singhal A, Krupanandan R, Gupta M, Sharma S, Chandankhede SR, Samantaray DJ, Saravanabavan L, Gundlapally S, Kurhade AA, Goyal M, Gupta N, Jeswani DR, Kumar A, Periwal R, Hegde A, Gupta A, Kaur J, Patel SJ, Nokewal S, Shaikh A, Karan P, Kapalavai SK, Ahmed M, Raviraj GS, Kolar B, Jeswani D, Sodhi K.   +32 more
europepmc   +1 more source